 |
|
 |
| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
69 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
69 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
78 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
98 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
150 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
233 |
| 424/264.1 |
Mycoplasma |
46 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
93 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
90 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
107 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
299 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
329 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
94 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
82 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6051237 |
Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
Apr. 18, 2000 |
| 6051416 |
Methods for producing enhanced antigenic Helicobacter sp. |
Apr. 18, 2000 |
| 6051552 |
Lactobacillus therapies |
Apr. 18, 2000 |
| 6048530 |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
Apr. 11, 2000 |
| 6045804 |
Method for detecting B. burgdorferi infection |
Apr. 4, 2000 |
| 6042837 |
Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC) |
Mar. 28, 2000 |
| 6039959 |
Treatment and diagnosis of infections due to helicobacter pylori |
Mar. 21, 2000 |
| 6036950 |
Method for improving utilisation of nutrients by ruminant or ruminant-like animals |
Mar. 14, 2000 |
| 6036953 |
Heterologous antigens in live cell V. cholerae strains |
Mar. 14, 2000 |
| 6030618 |
Therapeutic and prophylactic methods using heat shock proteins |
Feb. 29, 2000 |
| 6030625 |
Bordetella pertussis and Bordetella parapertussis strains |
Feb. 29, 2000 |
| 6027731 |
Pertussis toxin induced lymphocytosis |
Feb. 22, 2000 |
| 6027732 |
Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
Feb. 22, 2000 |
| 6027733 |
Method for generating saccharide fragments |
Feb. 22, 2000 |
| 6024964 |
Membrane anchor/active compound conjugate, its preparation and its uses |
Feb. 15, 2000 |
| 6022728 |
Method for producing a bacterial vaccine and novel vaccines produced thereby |
Feb. 8, 2000 |
| 6019981 |
Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish |
Feb. 1, 2000 |
| 6019982 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Feb. 1, 2000 |
| 6019985 |
Immunostimulation methods for providing disease protection in poultry |
Feb. 1, 2000 |
| 6017534 |
Hybrid Bacillus thuringiensis .delta.-endotoxins with novel broad-spectrum insecticidal activity |
Jan. 25, 2000 |
| 6015560 |
Antibody recognizing endothelial cell ligand for leukocyte CR3 |
Jan. 18, 2000 |
| 6015691 |
Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis |
Jan. 18, 2000 |
| 6015694 |
Method for stimulating an immune response utilizing recombinant alphavirus particles |
Jan. 18, 2000 |
| 6013266 |
Live attenuated bacteria of the species Actinobacillus pleuropneumoniae |
Jan. 11, 2000 |
| 6010705 |
Attenuated, invasive vaccines against fish pathogens |
Jan. 4, 2000 |
| 6004562 |
Outer membrane protein B1 of Moraxella catarrhalis |
Dec. 21, 1999 |
| 6004563 |
Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
Dec. 21, 1999 |
| 6001348 |
Non-virulent Mycoplasma synoviae and vaccine thereof |
Dec. 14, 1999 |
| 6001361 |
Mycobacterium vaccae antigens |
Dec. 14, 1999 |
| 6001372 |
Antigenic peptides of Chlamydia trachomatis |
Dec. 14, 1999 |
| 5997881 |
Method of making non-pyrogenic lipopolysaccharide or A |
Dec. 7, 1999 |
| 5993852 |
Biphasic lipid vesicle composition for transdermal administration of an immunogen |
Nov. 30, 1999 |
| 5989542 |
Capsular polysaccharides from enterococci |
Nov. 23, 1999 |
| 5989547 |
Leptospiral outer membrane proteins |
Nov. 23, 1999 |
| 5989553 |
Expression library immunization |
Nov. 23, 1999 |
| 5989841 |
Polypeptides and nucleic acids derived from Salmonella typhi and detection of Salmonella using thereof |
Nov. 23, 1999 |
| 5990266 |
Degradable polyesters, a mixed culture of microorganisms for degrading these polyesters, and methods for making these substances |
Nov. 23, 1999 |
| 5985264 |
IL-12 Stimulation of Neonatal immunity |
Nov. 16, 1999 |
| 5985284 |
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
Nov. 16, 1999 |
| 5985285 |
Vaccines for plague |
Nov. 16, 1999 |
| 5985288 |
Outer membrane protein P1 and peptides of Haemophilus influenzae type B |
Nov. 16, 1999 |
| 5981213 |
Methods and compositions relating to useful antigens of moraxella catarrhalis |
Nov. 9, 1999 |
| 5976536 |
Neisseria mutants, lipooligosaccharides and immunogenic compositions |
Nov. 2, 1999 |
| 5976539 |
Compositions and methods for use of IL-12 as an adjuvant |
Nov. 2, 1999 |
| 5976543 |
12-kDa protein derived from M. Tuberculosis useful for treatment of autoimmune diseases |
Nov. 2, 1999 |
| 5972336 |
Urease-based vaccine against helicobacter infection |
Oct. 26, 1999 |
| 5972348 |
Helicobacter pylori nickel binding protein |
Oct. 26, 1999 |
| 5968512 |
Antibody recognizing endothelial cell ligand for leukocyte CR3 |
Oct. 19, 1999 |
| 5968525 |
Inactivated Mycolplasma hyopneumoniae and uses therefor |
Oct. 19, 1999 |
| 5968548 |
Use of liposome encapsulated cirprofloxacin as an immunotherapeutic drug |
Oct. 19, 1999 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
